Trending News Today: FDA Temporarily Allowing Certain Impurity-Containing Losartan Products

The FDA said it will temporarily allow certain manufacturers to sell losartan medications containing specified levels of a probable cancer-causing impurity to maintain adequate supplies of the drug, Reuters reported. According to the article, losartan medicines on the market that contain N-Nitroso-N-methyl-4-aminobutyric acid above the acceptable limit of 0.96 parts per million (ppm) and below 9.82 ppm will be allowed until the impurity can be eliminated. The FDA noted that it expects companies to be able to manufacture losartan without the impurity and replenish supplies in approximately 6 months, the article reported.
 
A new report by the National Academies of Sciences, Engineering and Medicine suggests that prescription medications used to treat opioid addiction are vastly underused in the United States, The Associated Press reported. According to the report, the group called for increased prescribing of the drugs and other changes to reduce barriers to their use, which includes stigma, restrictions, and lack of training. The report concluded that patients taking opioid addiction medications have better long-term outcomes and are 50% less likely to die than if they weren’t on them, the article noted. 
 
New findings from a recent CDC report indicate that fentanyl-related deaths among young adults have sharply increased in the United States, NPR reported. According to the article, the report showed a 113% average annual increase from 2013 to 2016 when adjusted for age, with higher rates among African Americans and Latinos disproportionately. Increased trafficking of the drug and increased use are both contributing to the spike in fentanyl deaths, since the drug is easier to produce, the article reported.
 
 
 
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$